PRKAA1 and acute lymphoblastic leukemia: Given the numerous studies evaluating the role of mTORC1 signaling and its therapeutic targeting in T-ALL [9,38], we focused our research on the role of AMPK signaling in T-ALL and its crosstalk with HH signaling.